Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genetic Vectors | 66 | 2014 | 3404 | 1.700 |
Why?
|
Retroviridae | 49 | 2004 | 847 | 1.460 |
Why?
|
Gene Transfer Techniques | 26 | 2014 | 1216 | 1.400 |
Why?
|
Transfection | 48 | 2009 | 5743 | 1.060 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 26 | 2013 | 891 | 1.050 |
Why?
|
Hematopoietic Stem Cells | 27 | 2011 | 3401 | 0.800 |
Why?
|
Transduction, Genetic | 21 | 2010 | 898 | 0.800 |
Why?
|
Moloney murine leukemia virus | 18 | 2004 | 110 | 0.760 |
Why?
|
Genetic Engineering | 15 | 2007 | 933 | 0.670 |
Why?
|
RNA, Catalytic | 3 | 2007 | 52 | 0.560 |
Why?
|
Receptors, Dopamine D4 | 2 | 2014 | 168 | 0.550 |
Why?
|
Minisatellite Repeats | 2 | 2014 | 162 | 0.550 |
Why?
|
Lentivirus | 5 | 2009 | 518 | 0.540 |
Why?
|
Bone Marrow Transplantation | 15 | 2007 | 2729 | 0.530 |
Why?
|
Cancer Vaccines | 14 | 2013 | 1044 | 0.510 |
Why?
|
Adenoviridae | 12 | 2008 | 1092 | 0.430 |
Why?
|
Globins | 7 | 1995 | 406 | 0.420 |
Why?
|
Bone Marrow Cells | 9 | 2007 | 2412 | 0.420 |
Why?
|
Genes | 13 | 1994 | 1825 | 0.410 |
Why?
|
Receptors, Growth Factor | 4 | 2002 | 324 | 0.400 |
Why?
|
beta-Galactosidase | 12 | 2006 | 572 | 0.390 |
Why?
|
Mice | 130 | 2011 | 81819 | 0.370 |
Why?
|
Melanoma, Experimental | 5 | 2007 | 558 | 0.370 |
Why?
|
Gene Expression Regulation | 23 | 2007 | 11888 | 0.350 |
Why?
|
Animal Experimentation | 1 | 2010 | 46 | 0.340 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 4 | 2008 | 548 | 0.330 |
Why?
|
Animals | 159 | 2011 | 168764 | 0.320 |
Why?
|
Brain Mapping | 3 | 2014 | 6601 | 0.310 |
Why?
|
Reward | 2 | 2014 | 981 | 0.300 |
Why?
|
Hematopoietic Stem Cell Transplantation | 11 | 2013 | 5753 | 0.300 |
Why?
|
Cell Line | 40 | 2009 | 15543 | 0.290 |
Why?
|
Tumor Cells, Cultured | 19 | 2007 | 6113 | 0.270 |
Why?
|
Peptide Chain Termination, Translational | 1 | 2006 | 29 | 0.270 |
Why?
|
Adenosine Deaminase | 4 | 1997 | 251 | 0.260 |
Why?
|
Transgenes | 2 | 2006 | 1015 | 0.260 |
Why?
|
Hematopoiesis | 8 | 2005 | 2058 | 0.260 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2009 | 394 | 0.260 |
Why?
|
Codon, Terminator | 1 | 2006 | 125 | 0.260 |
Why?
|
Receptor Protein-Tyrosine Kinases | 4 | 2002 | 1624 | 0.260 |
Why?
|
Biological Assay | 1 | 2009 | 627 | 0.250 |
Why?
|
Executive Function | 1 | 2014 | 1391 | 0.250 |
Why?
|
Antigens, Neoplasm | 8 | 2007 | 2002 | 0.250 |
Why?
|
Proviruses | 2 | 2005 | 319 | 0.240 |
Why?
|
Publishing | 3 | 2010 | 835 | 0.240 |
Why?
|
Recombination, Genetic | 10 | 2001 | 1525 | 0.230 |
Why?
|
Intelligence | 2 | 2011 | 923 | 0.230 |
Why?
|
DNA, Recombinant | 11 | 1989 | 455 | 0.230 |
Why?
|
Cognition Disorders | 2 | 2011 | 3967 | 0.230 |
Why?
|
Sick Role | 1 | 2005 | 229 | 0.230 |
Why?
|
Language | 2 | 2005 | 1550 | 0.220 |
Why?
|
Guidelines as Topic | 1 | 2010 | 1394 | 0.220 |
Why?
|
Dependovirus | 4 | 2012 | 721 | 0.220 |
Why?
|
Blood Vessel Prosthesis | 3 | 2002 | 912 | 0.210 |
Why?
|
Small Molecule Libraries | 1 | 2009 | 741 | 0.210 |
Why?
|
Recombinant Fusion Proteins | 8 | 2002 | 3737 | 0.210 |
Why?
|
Plasminogen Activator Inhibitor 1 | 5 | 1995 | 282 | 0.210 |
Why?
|
RNA | 6 | 2011 | 2717 | 0.210 |
Why?
|
Mice, Inbred C57BL | 28 | 2009 | 22332 | 0.200 |
Why?
|
Immunologic Deficiency Syndromes | 1 | 2006 | 548 | 0.200 |
Why?
|
Graft Occlusion, Vascular | 2 | 2003 | 540 | 0.200 |
Why?
|
Pulmonary Alveoli | 1 | 2005 | 664 | 0.200 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2006 | 1167 | 0.200 |
Why?
|
Cells, Cultured | 43 | 2009 | 18973 | 0.200 |
Why?
|
Endothelium, Vascular | 9 | 2005 | 4427 | 0.200 |
Why?
|
Impulsive Behavior | 2 | 2014 | 344 | 0.190 |
Why?
|
Genes, Reporter | 5 | 2009 | 1524 | 0.190 |
Why?
|
Respiratory Mucosa | 1 | 2005 | 438 | 0.190 |
Why?
|
Interleukin-3 | 5 | 1998 | 423 | 0.190 |
Why?
|
Brain | 8 | 2014 | 27171 | 0.190 |
Why?
|
Dendritic Cells | 5 | 2003 | 2747 | 0.190 |
Why?
|
Fibrinolysis | 5 | 1996 | 331 | 0.190 |
Why?
|
Simian virus 40 | 9 | 1992 | 290 | 0.180 |
Why?
|
Proto-Oncogene Proteins | 5 | 2006 | 4520 | 0.180 |
Why?
|
Cell Division | 15 | 2004 | 4475 | 0.180 |
Why?
|
Neovascularization, Pathologic | 7 | 2008 | 2631 | 0.180 |
Why?
|
Periodicals as Topic | 2 | 2010 | 1462 | 0.180 |
Why?
|
Genes, Viral | 10 | 1988 | 654 | 0.180 |
Why?
|
Embryonic and Fetal Development | 3 | 2001 | 419 | 0.170 |
Why?
|
Base Sequence | 23 | 2007 | 12403 | 0.170 |
Why?
|
Sarcoglycans | 2 | 2012 | 57 | 0.170 |
Why?
|
Vesicular stomatitis Indiana virus | 2 | 1999 | 93 | 0.170 |
Why?
|
Liver | 8 | 2011 | 7562 | 0.170 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 2 | 2015 | 3719 | 0.170 |
Why?
|
Luminescent Proteins | 3 | 2006 | 839 | 0.170 |
Why?
|
Plasminogen Activators | 3 | 1996 | 200 | 0.170 |
Why?
|
T-Lymphocytes, Cytotoxic | 4 | 2002 | 1801 | 0.170 |
Why?
|
Muscular Dystrophies, Limb-Girdle | 2 | 2012 | 62 | 0.170 |
Why?
|
Transformation, Genetic | 6 | 1992 | 194 | 0.160 |
Why?
|
Gene Expression | 16 | 2009 | 7584 | 0.160 |
Why?
|
Muscular Dystrophy, Animal | 1 | 1999 | 89 | 0.160 |
Why?
|
Lymphocytes | 7 | 2006 | 2599 | 0.160 |
Why?
|
Mice, Inbred Strains | 11 | 2007 | 1770 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-abl | 2 | 2006 | 145 | 0.150 |
Why?
|
Nucleoside Deaminases | 2 | 1990 | 58 | 0.150 |
Why?
|
Dystrophin | 1 | 1999 | 283 | 0.150 |
Why?
|
Viral Envelope Proteins | 3 | 2009 | 640 | 0.150 |
Why?
|
Glycoproteins | 1 | 2005 | 2195 | 0.150 |
Why?
|
Gaucher Disease | 3 | 1995 | 110 | 0.140 |
Why?
|
Immunotherapy | 7 | 2011 | 4752 | 0.140 |
Why?
|
Blotting, Southern | 6 | 1994 | 772 | 0.140 |
Why?
|
Tetrahydrofolate Dehydrogenase | 5 | 1989 | 133 | 0.140 |
Why?
|
Nicotine | 2 | 2014 | 682 | 0.140 |
Why?
|
Molecular Sequence Data | 17 | 2007 | 17594 | 0.140 |
Why?
|
Melanoma | 7 | 2007 | 5719 | 0.140 |
Why?
|
Cell Transformation, Viral | 8 | 1989 | 527 | 0.140 |
Why?
|
3T3 Cells | 8 | 2002 | 1081 | 0.140 |
Why?
|
Plasmids | 14 | 2001 | 2274 | 0.130 |
Why?
|
Enzyme Inhibitors | 2 | 2006 | 3715 | 0.130 |
Why?
|
Neoplasm Proteins | 5 | 2007 | 3596 | 0.130 |
Why?
|
Toyocamycin | 2 | 2006 | 4 | 0.130 |
Why?
|
Membrane Glycoproteins | 7 | 2009 | 3690 | 0.120 |
Why?
|
Humans | 115 | 2015 | 765968 | 0.120 |
Why?
|
Vaccination | 8 | 2013 | 3426 | 0.120 |
Why?
|
Regulatory Sequences, Nucleic Acid | 3 | 1995 | 792 | 0.120 |
Why?
|
Fibrosarcoma | 2 | 1997 | 313 | 0.120 |
Why?
|
Cloning, Molecular | 13 | 2002 | 4165 | 0.120 |
Why?
|
Longitudinal Studies | 5 | 2015 | 14751 | 0.120 |
Why?
|
Embryo, Mammalian | 5 | 2005 | 1673 | 0.120 |
Why?
|
Nuclear Proteins | 3 | 2006 | 5783 | 0.120 |
Why?
|
Genes, Lethal | 2 | 1994 | 224 | 0.120 |
Why?
|
Neovascularization, Physiologic | 4 | 2008 | 1375 | 0.120 |
Why?
|
Pancreatic Neoplasms | 2 | 2002 | 5444 | 0.120 |
Why?
|
Bone Marrow | 6 | 2005 | 2921 | 0.110 |
Why?
|
Research Design | 1 | 2010 | 6209 | 0.110 |
Why?
|
Endothelial Growth Factors | 3 | 2002 | 680 | 0.110 |
Why?
|
Hypersensitivity, Delayed | 7 | 2003 | 490 | 0.110 |
Why?
|
Social Control, Informal | 1 | 2014 | 44 | 0.110 |
Why?
|
Interleukin-12 | 1 | 1997 | 579 | 0.110 |
Why?
|
Urokinase-Type Plasminogen Activator | 4 | 1996 | 323 | 0.110 |
Why?
|
Twins | 1 | 2015 | 341 | 0.110 |
Why?
|
Lymphokines | 3 | 2002 | 911 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2001 | 1429 | 0.110 |
Why?
|
Cell Separation | 5 | 2004 | 1718 | 0.110 |
Why?
|
Diseases in Twins | 1 | 2015 | 448 | 0.110 |
Why?
|
Green Fluorescent Proteins | 5 | 2010 | 2060 | 0.110 |
Why?
|
Immunotherapy, Adoptive | 3 | 2007 | 1510 | 0.110 |
Why?
|
Epithelial Cells | 1 | 2005 | 3681 | 0.110 |
Why?
|
Methotrexate | 3 | 1989 | 1722 | 0.110 |
Why?
|
Mice, Inbred BALB C | 10 | 2011 | 6220 | 0.100 |
Why?
|
Conditioning, Operant | 1 | 2014 | 306 | 0.100 |
Why?
|
Recombinant Proteins | 7 | 2008 | 6493 | 0.100 |
Why?
|
RNA Splicing | 6 | 1996 | 903 | 0.100 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 5 | 2006 | 660 | 0.100 |
Why?
|
Cytomegalovirus | 2 | 2008 | 751 | 0.100 |
Why?
|
Parathyroid Hormone | 5 | 1996 | 1789 | 0.100 |
Why?
|
HLA-D Antigens | 3 | 1987 | 130 | 0.100 |
Why?
|
Pentosyltransferases | 3 | 1981 | 63 | 0.100 |
Why?
|
DNA | 18 | 2004 | 7202 | 0.100 |
Why?
|
Leptin | 1 | 2001 | 1596 | 0.100 |
Why?
|
Genomic Instability | 2 | 2008 | 718 | 0.100 |
Why?
|
Muscle, Skeletal | 4 | 2008 | 4958 | 0.100 |
Why?
|
Oxygen | 3 | 2014 | 4241 | 0.100 |
Why?
|
Carcinoma, Renal Cell | 5 | 2004 | 3181 | 0.100 |
Why?
|
Kidney Neoplasms | 6 | 2004 | 4274 | 0.100 |
Why?
|
Osteochondrodysplasias | 1 | 1994 | 183 | 0.100 |
Why?
|
Memory, Short-Term | 2 | 2010 | 1003 | 0.100 |
Why?
|
Graft Survival | 6 | 2005 | 3890 | 0.100 |
Why?
|
Transplantation, Heterologous | 7 | 2008 | 2394 | 0.100 |
Why?
|
Kidney | 6 | 2000 | 7066 | 0.100 |
Why?
|
Leukemia, Erythroblastic, Acute | 4 | 1995 | 175 | 0.090 |
Why?
|
Viral Proteins | 4 | 1988 | 1797 | 0.090 |
Why?
|
Transcription, Genetic | 15 | 2002 | 7599 | 0.090 |
Why?
|
Wisconsin | 1 | 2011 | 121 | 0.090 |
Why?
|
HLA-DR Antigens | 4 | 2004 | 608 | 0.090 |
Why?
|
Immunotherapy, Active | 2 | 2006 | 58 | 0.090 |
Why?
|
Avian leukosis virus | 2 | 2001 | 18 | 0.090 |
Why?
|
Proteins | 6 | 2008 | 5995 | 0.090 |
Why?
|
T-Lymphocytes | 11 | 2009 | 10261 | 0.090 |
Why?
|
Luciferases | 2 | 2006 | 713 | 0.090 |
Why?
|
Genetic Markers | 2 | 2005 | 2601 | 0.090 |
Why?
|
Leukemia Virus, Murine | 3 | 1989 | 96 | 0.090 |
Why?
|
RNA, Messenger | 17 | 2008 | 12768 | 0.090 |
Why?
|
Social Environment | 1 | 2015 | 1011 | 0.090 |
Why?
|
Dementia | 2 | 2005 | 2744 | 0.090 |
Why?
|
Transplantation, Autologous | 6 | 2013 | 2120 | 0.090 |
Why?
|
Interleukin-2 | 4 | 1996 | 1896 | 0.090 |
Why?
|
Adenosine | 2 | 2006 | 806 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2013 | 4642 | 0.090 |
Why?
|
Suppression, Genetic | 1 | 1990 | 190 | 0.090 |
Why?
|
Growth Hormone | 2 | 1994 | 566 | 0.090 |
Why?
|
Epidermis | 3 | 1994 | 538 | 0.090 |
Why?
|
Cell Line, Transformed | 5 | 2007 | 858 | 0.090 |
Why?
|
Female | 51 | 2015 | 396112 | 0.080 |
Why?
|
Mice, Transgenic | 11 | 2006 | 9550 | 0.080 |
Why?
|
Endostatins | 2 | 2008 | 167 | 0.080 |
Why?
|
Major Histocompatibility Complex | 3 | 1987 | 879 | 0.080 |
Why?
|
Adenocarcinoma | 3 | 2002 | 6364 | 0.080 |
Why?
|
Male | 49 | 2015 | 363698 | 0.080 |
Why?
|
Tissue Plasminogen Activator | 4 | 1996 | 1167 | 0.080 |
Why?
|
Clone Cells | 4 | 2009 | 1672 | 0.080 |
Why?
|
Wechsler Scales | 2 | 2012 | 255 | 0.080 |
Why?
|
Neostriatum | 1 | 2010 | 231 | 0.080 |
Why?
|
Receptors, LDL | 2 | 1990 | 491 | 0.080 |
Why?
|
Decision Making | 2 | 2014 | 3965 | 0.080 |
Why?
|
Weight Loss | 1 | 2001 | 2710 | 0.080 |
Why?
|
Antigens, Differentiation | 2 | 2004 | 919 | 0.080 |
Why?
|
Receptors, Interleukin-2 | 2 | 1990 | 561 | 0.080 |
Why?
|
Mice, Nude | 6 | 2008 | 3618 | 0.080 |
Why?
|
alpha 1-Antitrypsin | 1 | 2009 | 168 | 0.080 |
Why?
|
Cues | 1 | 2014 | 877 | 0.080 |
Why?
|
Promoter Regions, Genetic | 12 | 2008 | 5786 | 0.080 |
Why?
|
Immunization | 1 | 1993 | 1219 | 0.080 |
Why?
|
Glucosylceramidase | 4 | 1996 | 124 | 0.080 |
Why?
|
Mouth Diseases | 2 | 2001 | 240 | 0.080 |
Why?
|
Glioblastoma | 3 | 2009 | 3459 | 0.080 |
Why?
|
Cell Movement | 5 | 2004 | 5194 | 0.080 |
Why?
|
Choice Behavior | 1 | 2014 | 844 | 0.070 |
Why?
|
Arteries | 2 | 1996 | 1118 | 0.070 |
Why?
|
Cell Transplantation | 5 | 2002 | 473 | 0.070 |
Why?
|
Nicotinic Agonists | 1 | 2010 | 266 | 0.070 |
Why?
|
Pattern Recognition, Physiological | 1 | 2007 | 14 | 0.070 |
Why?
|
Fluorouracil | 3 | 2006 | 1648 | 0.070 |
Why?
|
Verbal Learning | 1 | 2010 | 461 | 0.070 |
Why?
|
Amygdala | 2 | 2014 | 1377 | 0.070 |
Why?
|
Retinoblastoma | 1 | 1990 | 316 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2014 | 20124 | 0.070 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2008 | 182 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 5 | 2007 | 3513 | 0.070 |
Why?
|
Emphysema | 1 | 2009 | 234 | 0.070 |
Why?
|
Macrophages, Alveolar | 1 | 2009 | 413 | 0.070 |
Why?
|
Leukemia | 1 | 1995 | 1522 | 0.070 |
Why?
|
Phosphoproteins | 3 | 2004 | 2446 | 0.070 |
Why?
|
Islets of Langerhans Transplantation | 2 | 2004 | 746 | 0.070 |
Why?
|
Immunoglobulin lambda-Chains | 1 | 1987 | 84 | 0.070 |
Why?
|
Receptors, Virus | 2 | 2001 | 651 | 0.070 |
Why?
|
Blastocyst | 2 | 1989 | 432 | 0.070 |
Why?
|
Organ Specificity | 3 | 2004 | 1965 | 0.070 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2007 | 182 | 0.070 |
Why?
|
Mice, Knockout | 11 | 2008 | 14448 | 0.070 |
Why?
|
Neoplasms, Experimental | 3 | 2008 | 1229 | 0.070 |
Why?
|
Tubercidin | 1 | 2006 | 14 | 0.070 |
Why?
|
Acridine Orange | 1 | 2006 | 28 | 0.070 |
Why?
|
Ethidium | 1 | 2006 | 27 | 0.070 |
Why?
|
Verbal Behavior | 1 | 2007 | 328 | 0.070 |
Why?
|
Schistosoma mansoni | 1 | 2007 | 154 | 0.070 |
Why?
|
Phonetics | 1 | 2007 | 207 | 0.070 |
Why?
|
Luciferases, Firefly | 1 | 2006 | 36 | 0.060 |
Why?
|
Cytidine | 1 | 2006 | 59 | 0.060 |
Why?
|
Bone Marrow Diseases | 1 | 2008 | 234 | 0.060 |
Why?
|
Oligonucleotides, Antisense | 1 | 2009 | 462 | 0.060 |
Why?
|
Pulmonary Surfactants | 3 | 1996 | 169 | 0.060 |
Why?
|
Rabbits | 10 | 2003 | 4734 | 0.060 |
Why?
|
Neuropsychological Tests | 4 | 2012 | 7123 | 0.060 |
Why?
|
Mice, Inbred C3H | 4 | 1997 | 914 | 0.060 |
Why?
|
Antigens, CD34 | 4 | 2004 | 656 | 0.060 |
Why?
|
Uridine | 1 | 2006 | 135 | 0.060 |
Why?
|
Vascular Endothelial Growth Factors | 3 | 2002 | 754 | 0.060 |
Why?
|
Aminoglycosides | 1 | 2006 | 161 | 0.060 |
Why?
|
Biomimetics | 1 | 2007 | 168 | 0.060 |
Why?
|
Pulmonary Surfactant-Associated Protein C | 1 | 2005 | 30 | 0.060 |
Why?
|
PPAR alpha | 1 | 2007 | 175 | 0.060 |
Why?
|
Chemokines, CXC | 1 | 2007 | 416 | 0.060 |
Why?
|
Gentamicins | 1 | 2006 | 244 | 0.060 |
Why?
|
Amino Acid Sequence | 11 | 2002 | 13400 | 0.060 |
Why?
|
Blotting, Western | 6 | 2001 | 5020 | 0.060 |
Why?
|
Solubility | 2 | 2008 | 1078 | 0.060 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2010 | 624 | 0.060 |
Why?
|
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 230 | 0.060 |
Why?
|
Genes, Bacterial | 4 | 1985 | 1077 | 0.060 |
Why?
|
Transplantation Chimera | 2 | 2005 | 609 | 0.060 |
Why?
|
Papillomaviridae | 2 | 1988 | 1141 | 0.060 |
Why?
|
Spleen | 4 | 1996 | 2296 | 0.060 |
Why?
|
Radiation Chimera | 4 | 2007 | 216 | 0.060 |
Why?
|
Attention | 1 | 2015 | 2419 | 0.060 |
Why?
|
Acetanilides | 1 | 2006 | 167 | 0.060 |
Why?
|
Granulocytes | 1 | 2007 | 549 | 0.060 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2741 | 0.060 |
Why?
|
K562 Cells | 3 | 2013 | 649 | 0.060 |
Why?
|
Aging | 4 | 2014 | 8731 | 0.060 |
Why?
|
Guanine | 1 | 2006 | 282 | 0.060 |
Why?
|
Family | 1 | 2015 | 3209 | 0.060 |
Why?
|
Pulmonary Alveolar Proteinosis | 2 | 1996 | 41 | 0.060 |
Why?
|
Telomere | 1 | 2011 | 943 | 0.060 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 2 | 1981 | 70 | 0.060 |
Why?
|
Immunoconjugates | 2 | 2004 | 981 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 8 | 2014 | 36532 | 0.060 |
Why?
|
Base Pairing | 1 | 2004 | 139 | 0.060 |
Why?
|
DNA, Viral | 8 | 1989 | 2199 | 0.060 |
Why?
|
Chemotaxis | 1 | 2007 | 596 | 0.060 |
Why?
|
Stem Cells | 6 | 2007 | 3540 | 0.060 |
Why?
|
Switzerland | 1 | 2005 | 322 | 0.060 |
Why?
|
Endonucleases | 1 | 2006 | 372 | 0.050 |
Why?
|
Adenoviruses, Human | 1 | 1985 | 258 | 0.050 |
Why?
|
Adolescent | 11 | 2015 | 88835 | 0.050 |
Why?
|
Genotype | 3 | 2014 | 13024 | 0.050 |
Why?
|
Interleukin-6 | 4 | 2004 | 3222 | 0.050 |
Why?
|
France | 1 | 2005 | 495 | 0.050 |
Why?
|
Antigen-Presenting Cells | 1 | 2007 | 962 | 0.050 |
Why?
|
Mast Cells | 2 | 2003 | 1412 | 0.050 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 1988 | 394 | 0.050 |
Why?
|
Lymphangiogenesis | 1 | 2004 | 171 | 0.050 |
Why?
|
Restriction Mapping | 3 | 1993 | 848 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2005 | 4562 | 0.050 |
Why?
|
RNA, Viral | 8 | 2000 | 2864 | 0.050 |
Why?
|
Sirtuins | 1 | 2006 | 322 | 0.050 |
Why?
|
Mice, Mutant Strains | 6 | 1998 | 1745 | 0.050 |
Why?
|
DNA Primers | 3 | 1998 | 2825 | 0.050 |
Why?
|
Catalysis | 1 | 2004 | 770 | 0.050 |
Why?
|
Swine, Miniature | 2 | 2002 | 971 | 0.050 |
Why?
|
Cognition | 2 | 2012 | 7049 | 0.050 |
Why?
|
Cricetinae | 3 | 2004 | 2411 | 0.050 |
Why?
|
Splenic Neoplasms | 1 | 2002 | 97 | 0.050 |
Why?
|
Receptors, Cell Surface | 2 | 2005 | 2817 | 0.050 |
Why?
|
Wiskott-Aldrich Syndrome | 1 | 2002 | 131 | 0.050 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2004 | 594 | 0.050 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2006 | 679 | 0.050 |
Why?
|
Membrane Proteins | 6 | 2007 | 7851 | 0.050 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2013 | 1646 | 0.050 |
Why?
|
Cytokines | 5 | 2009 | 7421 | 0.050 |
Why?
|
Erythropoietin | 1 | 2006 | 716 | 0.050 |
Why?
|
Molecular Weight | 3 | 1990 | 2163 | 0.050 |
Why?
|
Molecular Structure | 1 | 2006 | 1885 | 0.050 |
Why?
|
Species Specificity | 5 | 2004 | 2406 | 0.050 |
Why?
|
Depression | 1 | 2001 | 8237 | 0.050 |
Why?
|
Cell Surface Extensions | 1 | 2001 | 64 | 0.050 |
Why?
|
Oligonucleotides | 1 | 2004 | 561 | 0.050 |
Why?
|
Prostatic Neoplasms | 5 | 2006 | 11083 | 0.050 |
Why?
|
Blood Vessels | 2 | 2005 | 1113 | 0.050 |
Why?
|
Receptors, IgE | 1 | 2003 | 374 | 0.050 |
Why?
|
Tunica Intima | 1 | 2003 | 455 | 0.050 |
Why?
|
Actins | 2 | 2001 | 2056 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2004 | 911 | 0.050 |
Why?
|
Cartilage | 2 | 1996 | 798 | 0.050 |
Why?
|
Gene Targeting | 4 | 2001 | 841 | 0.050 |
Why?
|
Cell Line, Tumor | 6 | 2011 | 17075 | 0.050 |
Why?
|
Wound Healing | 2 | 2007 | 2792 | 0.050 |
Why?
|
Antigens, Ly | 2 | 2007 | 296 | 0.050 |
Why?
|
Genetic Complementation Test | 2 | 2000 | 557 | 0.050 |
Why?
|
Glucokinase | 1 | 2001 | 98 | 0.050 |
Why?
|
Colonic Neoplasms | 1 | 1993 | 2531 | 0.050 |
Why?
|
B-Lymphocytes | 4 | 2007 | 4778 | 0.050 |
Why?
|
Genetic Diseases, Inborn | 1 | 2006 | 605 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4034 | 0.050 |
Why?
|
DNA-Binding Proteins | 4 | 2006 | 9601 | 0.050 |
Why?
|
Reading | 1 | 2005 | 539 | 0.050 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 2006 | 2900 | 0.050 |
Why?
|
Frontal Lobe | 1 | 2007 | 1410 | 0.050 |
Why?
|
Medulloblastoma | 1 | 2006 | 658 | 0.050 |
Why?
|
Lesch-Nyhan Syndrome | 1 | 1980 | 17 | 0.040 |
Why?
|
Phenotype | 7 | 2015 | 16721 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2006 | 1333 | 0.040 |
Why?
|
Adoptive Transfer | 1 | 2003 | 827 | 0.040 |
Why?
|
Fluorescent Dyes | 5 | 2004 | 1930 | 0.040 |
Why?
|
Benzimidazoles | 4 | 2002 | 864 | 0.040 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 2002 | 330 | 0.040 |
Why?
|
Collagen | 3 | 2001 | 2618 | 0.040 |
Why?
|
DNA Restriction Enzymes | 7 | 1987 | 548 | 0.040 |
Why?
|
Cell Adhesion | 1 | 2007 | 3089 | 0.040 |
Why?
|
Mice, Congenic | 1 | 2000 | 98 | 0.040 |
Why?
|
Translocation, Genetic | 1 | 2006 | 1394 | 0.040 |
Why?
|
Melanoma-Specific Antigens | 1 | 2000 | 75 | 0.040 |
Why?
|
AIDS-Related Opportunistic Infections | 2 | 2001 | 664 | 0.040 |
Why?
|
Thrombosis | 4 | 2002 | 2949 | 0.040 |
Why?
|
Antigens, CD | 4 | 2004 | 4025 | 0.040 |
Why?
|
Cerebellum | 1 | 2007 | 1518 | 0.040 |
Why?
|
Extracellular Matrix | 4 | 2001 | 1727 | 0.040 |
Why?
|
Nucleic Acid Hybridization | 4 | 1989 | 1306 | 0.040 |
Why?
|
Mice, Obese | 1 | 2001 | 417 | 0.040 |
Why?
|
Cultural Characteristics | 1 | 2001 | 250 | 0.040 |
Why?
|
Xerostomia | 1 | 2000 | 94 | 0.040 |
Why?
|
Cell Differentiation | 10 | 2007 | 11641 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2011 | 2942 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 3 | 2011 | 8923 | 0.040 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2001 | 437 | 0.040 |
Why?
|
Capillary Permeability | 2 | 2000 | 768 | 0.040 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2002 | 639 | 0.040 |
Why?
|
Neoplasms | 5 | 2011 | 22340 | 0.040 |
Why?
|
HeLa Cells | 3 | 2002 | 3067 | 0.040 |
Why?
|
Injections, Intramuscular | 2 | 1999 | 552 | 0.040 |
Why?
|
Polyglycolic Acid | 1 | 2001 | 406 | 0.040 |
Why?
|
Proteolipids | 2 | 1996 | 109 | 0.040 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2004 | 2423 | 0.040 |
Why?
|
Adenoviridae Infections | 1 | 1999 | 97 | 0.040 |
Why?
|
Brain Neoplasms | 3 | 2008 | 9071 | 0.040 |
Why?
|
Erythrocytes | 1 | 1988 | 2395 | 0.040 |
Why?
|
Macrophage Colony-Stimulating Factor | 2 | 1996 | 186 | 0.040 |
Why?
|
Homozygote | 3 | 1993 | 1775 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2001 | 1600 | 0.040 |
Why?
|
Lymph Nodes | 2 | 2003 | 3454 | 0.040 |
Why?
|
Mutagenesis | 3 | 2004 | 1228 | 0.040 |
Why?
|
Cell Lineage | 2 | 2005 | 2573 | 0.040 |
Why?
|
Pituitary Gland | 1 | 2001 | 631 | 0.040 |
Why?
|
Obesity | 1 | 2001 | 13076 | 0.040 |
Why?
|
Escherichia coli | 5 | 1988 | 4214 | 0.040 |
Why?
|
CD4 Lymphocyte Count | 4 | 2012 | 2587 | 0.040 |
Why?
|
Cerebral Ventricles | 1 | 2001 | 549 | 0.040 |
Why?
|
Gene Deletion | 3 | 1996 | 2666 | 0.040 |
Why?
|
Angiogenesis Inhibitors | 2 | 2006 | 2056 | 0.040 |
Why?
|
Fibroblasts | 6 | 2005 | 4159 | 0.040 |
Why?
|
Strongyloidiasis | 1 | 1998 | 27 | 0.040 |
Why?
|
Kanamycin Kinase | 3 | 1987 | 34 | 0.040 |
Why?
|
HIV Infections | 4 | 2012 | 17533 | 0.040 |
Why?
|
Mice, Inbred CBA | 2 | 1989 | 439 | 0.040 |
Why?
|
Genes, Tumor Suppressor | 1 | 2002 | 1061 | 0.040 |
Why?
|
Protein Structure, Tertiary | 2 | 2003 | 3750 | 0.040 |
Why?
|
Polymerase Chain Reaction | 3 | 1996 | 6069 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2001 | 561 | 0.040 |
Why?
|
Leg | 1 | 2002 | 1080 | 0.040 |
Why?
|
Mitochondria | 1 | 2011 | 3673 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2006 | 3608 | 0.040 |
Why?
|
Trans-Activators | 2 | 1997 | 2850 | 0.030 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2000 | 498 | 0.030 |
Why?
|
Fibrin | 3 | 1995 | 513 | 0.030 |
Why?
|
Mutation | 9 | 1993 | 30198 | 0.030 |
Why?
|
Endothelial Cells | 3 | 2005 | 3584 | 0.030 |
Why?
|
Creatine Kinase | 2 | 2008 | 682 | 0.030 |
Why?
|
Staining and Labeling | 2 | 2004 | 1072 | 0.030 |
Why?
|
Vaccines, Synthetic | 1 | 1999 | 621 | 0.030 |
Why?
|
Mice, Inbred DBA | 1 | 1998 | 623 | 0.030 |
Why?
|
Macaca mulatta | 4 | 2010 | 2341 | 0.030 |
Why?
|
Enhancer Elements, Genetic | 3 | 1989 | 1365 | 0.030 |
Why?
|
Phosphorylation | 5 | 2007 | 8278 | 0.030 |
Why?
|
Tetracycline | 1 | 1997 | 216 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2004 | 1995 | 0.030 |
Why?
|
Lymphocyte Activation | 5 | 2002 | 5501 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2003 | 3807 | 0.030 |
Why?
|
Phosphotransferases | 3 | 1987 | 302 | 0.030 |
Why?
|
Stress, Psychological | 1 | 2012 | 4533 | 0.030 |
Why?
|
Heparitin Sulfate | 2 | 1994 | 223 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2009 | 5881 | 0.030 |
Why?
|
Models, Genetic | 1 | 2006 | 3449 | 0.030 |
Why?
|
Capsid | 1 | 1999 | 435 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2002 | 2570 | 0.030 |
Why?
|
Carotid Stenosis | 1 | 2003 | 861 | 0.030 |
Why?
|
Parathyroid Hormone-Related Protein | 2 | 1996 | 327 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2003 | 1679 | 0.030 |
Why?
|
RNA-Directed DNA Polymerase | 1 | 1996 | 222 | 0.030 |
Why?
|
Priapism | 1 | 1996 | 28 | 0.030 |
Why?
|
Macrophages | 6 | 1998 | 5772 | 0.030 |
Why?
|
Thrombopoietin | 1 | 1998 | 225 | 0.030 |
Why?
|
Kidney Glomerulus | 2 | 2000 | 568 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2004 | 10729 | 0.030 |
Why?
|
Apoptosis | 3 | 2008 | 9514 | 0.030 |
Why?
|
Adult | 17 | 2014 | 223044 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 2002 | 1042 | 0.030 |
Why?
|
Fanconi Anemia | 1 | 1998 | 327 | 0.030 |
Why?
|
Basophils | 1 | 1998 | 392 | 0.030 |
Why?
|
Protein Biosynthesis | 5 | 1996 | 2086 | 0.030 |
Why?
|
Hypothalamus | 1 | 2001 | 993 | 0.030 |
Why?
|
Immunohistochemistry | 4 | 2010 | 11022 | 0.030 |
Why?
|
Lactic Acid | 1 | 2001 | 1137 | 0.030 |
Why?
|
Lung Neoplasms | 3 | 2004 | 13451 | 0.030 |
Why?
|
Verapamil | 1 | 1996 | 242 | 0.030 |
Why?
|
DNA, Bacterial | 1 | 1980 | 1477 | 0.030 |
Why?
|
Receptors, Parathyroid Hormone | 1 | 1996 | 332 | 0.030 |
Why?
|
DNA, Complementary | 2 | 1993 | 1984 | 0.030 |
Why?
|
Signal Transduction | 8 | 2008 | 23601 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2004 | 2143 | 0.030 |
Why?
|
Plastic Embedding | 1 | 1995 | 9 | 0.030 |
Why?
|
Rats | 11 | 2004 | 23707 | 0.030 |
Why?
|
Lymphocyte Depletion | 2 | 1997 | 605 | 0.030 |
Why?
|
Tissue Engineering | 1 | 2005 | 1855 | 0.030 |
Why?
|
Leukemia, Experimental | 1 | 1995 | 225 | 0.030 |
Why?
|
Kidney Diseases | 2 | 1996 | 2098 | 0.030 |
Why?
|
Chickens | 2 | 1995 | 842 | 0.030 |
Why?
|
Glucosylceramides | 1 | 1995 | 27 | 0.030 |
Why?
|
Mice, Neurologic Mutants | 1 | 1995 | 107 | 0.030 |
Why?
|
Ovulation | 1 | 1995 | 178 | 0.030 |
Why?
|
Neoplasm Metastasis | 3 | 2003 | 4893 | 0.030 |
Why?
|
Repetitive Sequences, Nucleic Acid | 4 | 1992 | 780 | 0.030 |
Why?
|
Penis | 1 | 1996 | 209 | 0.030 |
Why?
|
Long-Term Potentiation | 1 | 1996 | 290 | 0.030 |
Why?
|
Middle Aged | 20 | 2014 | 223009 | 0.030 |
Why?
|
Colony-Forming Units Assay | 2 | 2007 | 351 | 0.030 |
Why?
|
Erythroid Precursor Cells | 1 | 1995 | 211 | 0.030 |
Why?
|
Growth Plate | 1 | 1996 | 273 | 0.030 |
Why?
|
Oxidative Stress | 2 | 2002 | 3141 | 0.030 |
Why?
|
Nucleic Acid Conformation | 2 | 2007 | 901 | 0.030 |
Why?
|
Culture Media | 1 | 1996 | 890 | 0.030 |
Why?
|
Proteoglycans | 2 | 1994 | 793 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 1997 | 720 | 0.030 |
Why?
|
Animals, Newborn | 2 | 1991 | 2669 | 0.030 |
Why?
|
HIV | 2 | 2004 | 1585 | 0.030 |
Why?
|
Drug Resistance | 4 | 1988 | 1591 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2001 | 1275 | 0.030 |
Why?
|
Alleles | 3 | 2014 | 6897 | 0.030 |
Why?
|
Colitis | 1 | 2002 | 1239 | 0.030 |
Why?
|
Dogs | 2 | 1989 | 3822 | 0.030 |
Why?
|
In Situ Nick-End Labeling | 2 | 2008 | 610 | 0.030 |
Why?
|
Immunosuppressive Agents | 2 | 2004 | 4209 | 0.030 |
Why?
|
Blood | 1 | 1996 | 597 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2000 | 1365 | 0.030 |
Why?
|
Corneal Neovascularization | 2 | 2007 | 184 | 0.030 |
Why?
|
Individuality | 1 | 2015 | 303 | 0.030 |
Why?
|
Thymus Gland | 2 | 1991 | 1261 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 1997 | 13648 | 0.030 |
Why?
|
Megakaryocytes | 1 | 1998 | 557 | 0.030 |
Why?
|
Tissue Distribution | 3 | 2001 | 2266 | 0.030 |
Why?
|
Genomic Library | 1 | 1993 | 189 | 0.030 |
Why?
|
Immunoglobulin Joining Region | 1 | 1993 | 37 | 0.030 |
Why?
|
Fetal Blood | 1 | 2000 | 1369 | 0.030 |
Why?
|
Genes, RAG-1 | 1 | 1993 | 67 | 0.030 |
Why?
|
Polymers | 1 | 2001 | 1621 | 0.030 |
Why?
|
Lymphatic Metastasis | 2 | 2002 | 2887 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2000 | 1410 | 0.030 |
Why?
|
Mice, SCID | 3 | 2006 | 2630 | 0.030 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1996 | 435 | 0.030 |
Why?
|
Lac Operon | 3 | 1999 | 238 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1999 | 2505 | 0.030 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 1993 | 96 | 0.030 |
Why?
|
Peptides | 1 | 2005 | 4331 | 0.030 |
Why?
|
Bone Development | 1 | 1996 | 468 | 0.030 |
Why?
|
Autopsy | 1 | 1997 | 1011 | 0.030 |
Why?
|
Forecasting | 1 | 2002 | 2936 | 0.030 |
Why?
|
Cohort Studies | 2 | 2014 | 41649 | 0.030 |
Why?
|
Nerve Tissue Proteins | 2 | 2006 | 4392 | 0.030 |
Why?
|
Adenosine Triphosphate | 3 | 2011 | 1999 | 0.030 |
Why?
|
Aged | 12 | 2013 | 171117 | 0.030 |
Why?
|
Tissue Transplantation | 1 | 1993 | 128 | 0.030 |
Why?
|
Iliac Artery | 1 | 1994 | 330 | 0.030 |
Why?
|
Fibronectins | 2 | 1987 | 719 | 0.030 |
Why?
|
Genes, Immunoglobulin | 1 | 1993 | 285 | 0.020 |
Why?
|
Granulomatous Disease, Chronic | 1 | 1993 | 176 | 0.020 |
Why?
|
Human Growth Hormone | 1 | 1997 | 638 | 0.020 |
Why?
|
Radiation Protection | 1 | 1996 | 424 | 0.020 |
Why?
|
Eosinophilia | 1 | 1997 | 556 | 0.020 |
Why?
|
Analysis of Variance | 3 | 2009 | 6203 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 1994 | 939 | 0.020 |
Why?
|
Growth | 1 | 1994 | 365 | 0.020 |
Why?
|
Tubulin | 2 | 1986 | 692 | 0.020 |
Why?
|
Disease Models, Animal | 5 | 2007 | 18293 | 0.020 |
Why?
|
Cell Survival | 4 | 2004 | 5747 | 0.020 |
Why?
|
Codon | 1 | 1993 | 595 | 0.020 |
Why?
|
Bacterial Proteins | 2 | 2001 | 3837 | 0.020 |
Why?
|
Psychometrics | 1 | 2001 | 3062 | 0.020 |
Why?
|
Phagocytes | 1 | 1993 | 292 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 1999 | 1652 | 0.020 |
Why?
|
Kidney Tubules | 3 | 2000 | 453 | 0.020 |
Why?
|
Cell Proliferation | 4 | 2011 | 10429 | 0.020 |
Why?
|
Glycosaminoglycans | 1 | 1994 | 606 | 0.020 |
Why?
|
Interleukin-4 | 1 | 1995 | 1162 | 0.020 |
Why?
|
Treatment Outcome | 6 | 2013 | 65188 | 0.020 |
Why?
|
Microtubules | 2 | 2008 | 1062 | 0.020 |
Why?
|
Combined Modality Therapy | 3 | 2013 | 8529 | 0.020 |
Why?
|
Kinetics | 4 | 2007 | 6274 | 0.020 |
Why?
|
Ovary | 1 | 1995 | 956 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2004 | 4913 | 0.020 |
Why?
|
Candidiasis, Oral | 2 | 2001 | 57 | 0.020 |
Why?
|
Neurons | 3 | 2002 | 9525 | 0.020 |
Why?
|
Hemostasis | 1 | 1993 | 467 | 0.020 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2004 | 1106 | 0.020 |
Why?
|
Inflammation | 3 | 2009 | 10850 | 0.020 |
Why?
|
Cell Nucleus | 1 | 1999 | 2867 | 0.020 |
Why?
|
Hyperparathyroidism | 1 | 1992 | 337 | 0.020 |
Why?
|
Chloramphenicol O-Acetyltransferase | 1 | 1990 | 220 | 0.020 |
Why?
|
Gene Amplification | 2 | 2006 | 1091 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 1996 | 1555 | 0.020 |
Why?
|
Proto-Oncogenes | 1 | 1991 | 320 | 0.020 |
Why?
|
Macromolecular Substances | 2 | 1990 | 1430 | 0.020 |
Why?
|
Avian Proteins | 2 | 2001 | 77 | 0.020 |
Why?
|
Statistics as Topic | 1 | 1997 | 2352 | 0.020 |
Why?
|
Mammals | 2 | 2002 | 1125 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2007 | 59489 | 0.020 |
Why?
|
Prevalence | 2 | 2005 | 15842 | 0.020 |
Why?
|
Keratinocytes | 1 | 1994 | 863 | 0.020 |
Why?
|
Antigens, Surface | 2 | 2003 | 1617 | 0.020 |
Why?
|
Gluconeogenesis | 1 | 2011 | 183 | 0.020 |
Why?
|
Hematocrit | 2 | 2006 | 621 | 0.020 |
Why?
|
Femoral Artery | 1 | 1994 | 811 | 0.020 |
Why?
|
Leukocytes, Mononuclear | 2 | 2009 | 1857 | 0.020 |
Why?
|
Young Adult | 2 | 2014 | 59889 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-jun | 1 | 1990 | 287 | 0.020 |
Why?
|
Survival Analysis | 1 | 2002 | 10070 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 2 | 2007 | 723 | 0.020 |
Why?
|
Osteogenesis | 1 | 1996 | 1282 | 0.020 |
Why?
|
Glucose | 1 | 2001 | 4335 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2001 | 14652 | 0.020 |
Why?
|
Viruses | 1 | 1993 | 371 | 0.020 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1993 | 1132 | 0.020 |
Why?
|
Vaccines | 1 | 1998 | 841 | 0.020 |
Why?
|
Hematologic Diseases | 1 | 1993 | 500 | 0.020 |
Why?
|
Tryptophan Synthase | 1 | 1988 | 9 | 0.020 |
Why?
|
Hemorrhage | 2 | 2008 | 3461 | 0.020 |
Why?
|
Models, Animal | 2 | 2006 | 2120 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2007 | 5891 | 0.020 |
Why?
|
Helper Viruses | 1 | 1988 | 39 | 0.020 |
Why?
|
Lymphopenia | 1 | 1991 | 297 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2000 | 4348 | 0.020 |
Why?
|
Cell Death | 2 | 2006 | 1679 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 3 | 1987 | 2844 | 0.020 |
Why?
|
Microbodies | 1 | 1988 | 34 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2001 | 5125 | 0.020 |
Why?
|
Glucose-6-Phosphatase | 1 | 1988 | 70 | 0.020 |
Why?
|
Chlorides | 1 | 1991 | 666 | 0.020 |
Why?
|
Hemin | 1 | 1988 | 51 | 0.020 |
Why?
|
Corpus Luteum | 1 | 2008 | 81 | 0.020 |
Why?
|
Virus Replication | 2 | 1989 | 2447 | 0.020 |
Why?
|
Caspase 3 | 1 | 2010 | 731 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 1999 | 4772 | 0.020 |
Why?
|
Exons | 1 | 2014 | 2391 | 0.020 |
Why?
|
Stereotaxic Techniques | 1 | 2010 | 551 | 0.020 |
Why?
|
Alcohol Oxidoreductases | 1 | 1988 | 164 | 0.020 |
Why?
|
Coculture Techniques | 2 | 2005 | 1336 | 0.020 |
Why?
|
Blood Coagulation | 1 | 1994 | 1166 | 0.020 |
Why?
|
Histidine | 1 | 1988 | 301 | 0.020 |
Why?
|
Chromosome Mapping | 3 | 1987 | 4618 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2006 | 9373 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 1990 | 576 | 0.020 |
Why?
|
SELEX Aptamer Technique | 1 | 2007 | 19 | 0.020 |
Why?
|
Regulatory Sequences, Ribonucleic Acid | 1 | 2007 | 29 | 0.020 |
Why?
|
R Factors | 1 | 1987 | 35 | 0.020 |
Why?
|
Glucuronosyltransferase | 1 | 1988 | 136 | 0.020 |
Why?
|
Antigen Presentation | 2 | 2007 | 1250 | 0.020 |
Why?
|
Autoimmune Diseases | 2 | 1996 | 2226 | 0.020 |
Why?
|
rap1 GTP-Binding Proteins | 1 | 2007 | 51 | 0.020 |
Why?
|
Blood Platelets | 1 | 1998 | 2464 | 0.020 |
Why?
|
Theophylline | 1 | 2007 | 132 | 0.020 |
Why?
|
Allosteric Site | 1 | 2007 | 106 | 0.020 |
Why?
|
MART-1 Antigen | 1 | 2007 | 65 | 0.020 |
Why?
|
Computational Biology | 1 | 1999 | 3559 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2003 | 1240 | 0.020 |
Why?
|
Metallothionein | 1 | 1987 | 62 | 0.020 |
Why?
|
Hematopoietic System | 1 | 2007 | 110 | 0.020 |
Why?
|
Histocytochemistry | 1 | 1988 | 696 | 0.020 |
Why?
|
Cell Cycle Proteins | 1 | 1998 | 3430 | 0.020 |
Why?
|
Retinoblastoma Protein | 1 | 1990 | 666 | 0.020 |
Why?
|
Doxorubicin | 2 | 2011 | 2230 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 1993 | 1612 | 0.020 |
Why?
|
Glucosidases | 1 | 1986 | 12 | 0.020 |
Why?
|
Insulin | 1 | 2001 | 6599 | 0.020 |
Why?
|
Carcinoma, Lewis Lung | 1 | 2007 | 106 | 0.020 |
Why?
|
Tunicamycin | 1 | 2006 | 107 | 0.020 |
Why?
|
Memory | 1 | 1996 | 2190 | 0.020 |
Why?
|
Tryptophan | 1 | 1988 | 483 | 0.020 |
Why?
|
Sarcoma Viruses, Murine | 1 | 1986 | 18 | 0.020 |
Why?
|
Time Factors | 6 | 2006 | 40065 | 0.020 |
Why?
|
HLA-DQ Antigens | 1 | 1987 | 190 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2002 | 9525 | 0.020 |
Why?
|
Ion Channels | 1 | 1991 | 1045 | 0.020 |
Why?
|
Transplantation Conditioning | 1 | 2013 | 1635 | 0.020 |
Why?
|
Cottontail rabbit papillomavirus | 1 | 1986 | 2 | 0.020 |
Why?
|
Incidence | 1 | 2005 | 21480 | 0.020 |
Why?
|
Injections, Intradermal | 1 | 2006 | 116 | 0.020 |
Why?
|
Salmonella typhimurium | 1 | 1988 | 348 | 0.020 |
Why?
|
Longevity | 1 | 1994 | 1087 | 0.020 |
Why?
|
Interleukin-15 | 1 | 2007 | 186 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2001 | 12976 | 0.020 |
Why?
|
Antigen-Antibody Reactions | 1 | 2006 | 340 | 0.020 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 1989 | 648 | 0.020 |
Why?
|
Protein Precursors | 2 | 1984 | 1134 | 0.020 |
Why?
|
Multiple Myeloma | 1 | 2004 | 5197 | 0.020 |
Why?
|
Allosteric Regulation | 1 | 2007 | 425 | 0.020 |
Why?
|
Half-Life | 1 | 2007 | 644 | 0.020 |
Why?
|
Safety | 1 | 2010 | 1157 | 0.020 |
Why?
|
Binding Sites | 2 | 1994 | 6001 | 0.020 |
Why?
|
Mice, Inbred NOD | 2 | 2001 | 1837 | 0.020 |
Why?
|
Epidermal Growth Factor | 1 | 1988 | 698 | 0.020 |
Why?
|
Drug Resistance, Microbial | 1 | 1989 | 833 | 0.020 |
Why?
|
Antigens, Viral, Tumor | 1 | 1986 | 151 | 0.020 |
Why?
|
Telomerase | 1 | 2011 | 749 | 0.020 |
Why?
|
Hyperlipidemias | 1 | 1990 | 770 | 0.020 |
Why?
|
RNA, Neoplasm | 1 | 2008 | 745 | 0.020 |
Why?
|
Pericytes | 1 | 2008 | 299 | 0.020 |
Why?
|
DNA, Mitochondrial | 1 | 2011 | 869 | 0.020 |
Why?
|
Thrombospondin 1 | 1 | 2007 | 256 | 0.020 |
Why?
|
Cystic Fibrosis | 2 | 1991 | 1287 | 0.020 |
Why?
|
Polycythemia | 1 | 2006 | 125 | 0.020 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2009 | 1347 | 0.020 |
Why?
|
Intermediate Filament Proteins | 1 | 2006 | 261 | 0.020 |
Why?
|
Chemokine CXCL12 | 1 | 2007 | 455 | 0.020 |
Why?
|
Polyomavirus | 1 | 1986 | 236 | 0.020 |
Why?
|
Myositis | 1 | 2008 | 270 | 0.020 |
Why?
|
Hybridomas | 2 | 2002 | 442 | 0.010 |
Why?
|
Myoblasts, Skeletal | 1 | 2005 | 74 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 1997 | 3850 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 1993 | 1811 | 0.010 |
Why?
|
Blotting, Northern | 2 | 2001 | 1546 | 0.010 |
Why?
|
Syndecan-4 | 2 | 1994 | 44 | 0.010 |
Why?
|
Carotid Arteries | 1 | 1989 | 929 | 0.010 |
Why?
|
CD4-CD8 Ratio | 1 | 2004 | 114 | 0.010 |
Why?
|
H-2 Antigens | 1 | 1985 | 359 | 0.010 |
Why?
|
Integrases | 1 | 2007 | 520 | 0.010 |
Why?
|
Prostate-Specific Antigen | 2 | 2006 | 2464 | 0.010 |
Why?
|
Patient Selection | 1 | 1997 | 4255 | 0.010 |
Why?
|
Liver Diseases | 1 | 1993 | 1303 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor D | 1 | 2004 | 61 | 0.010 |
Why?
|
Heterozygote | 1 | 1991 | 2794 | 0.010 |
Why?
|
Cyclophilin A | 1 | 2004 | 56 | 0.010 |
Why?
|
Antibodies, Monoclonal | 3 | 2002 | 9249 | 0.010 |
Why?
|
Oncogene Proteins, Viral | 1 | 1986 | 341 | 0.010 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1997 | 4405 | 0.010 |
Why?
|
Swine | 3 | 2002 | 5988 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2014 | 0.010 |
Why?
|
Microscopy, Fluorescence | 2 | 2001 | 2627 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2003 | 5389 | 0.010 |
Why?
|
Selection, Genetic | 3 | 1988 | 878 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-hck | 1 | 2004 | 46 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2004 | 124 | 0.010 |
Why?
|
Motivation | 1 | 2014 | 2018 | 0.010 |
Why?
|
NG-Nitroarginine Methyl Ester | 1 | 2004 | 261 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2012 | 1881 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 1993 | 2428 | 0.010 |
Why?
|
History, 20th Century | 1 | 1992 | 2761 | 0.010 |
Why?
|
Teratoma | 1 | 1986 | 401 | 0.010 |
Why?
|
Hippocampus | 1 | 1996 | 3775 | 0.010 |
Why?
|
Radiation Tolerance | 1 | 2006 | 475 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2014 | 4247 | 0.010 |
Why?
|
Physicians | 1 | 2001 | 4588 | 0.010 |
Why?
|
Structure-Activity Relationship | 2 | 2003 | 3051 | 0.010 |
Why?
|
Protein Kinases | 2 | 1991 | 1611 | 0.010 |
Why?
|
Oncogenes | 1 | 1989 | 1235 | 0.010 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2003 | 43 | 0.010 |
Why?
|
Bone and Bones | 1 | 1994 | 2554 | 0.010 |
Why?
|
Microscopy, Immunoelectron | 1 | 2003 | 315 | 0.010 |
Why?
|
Genomics | 1 | 1999 | 5929 | 0.010 |
Why?
|
Haplorhini | 2 | 1981 | 520 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1996 | 2159 | 0.010 |
Why?
|
Phosphotyrosine | 1 | 2004 | 459 | 0.010 |
Why?
|
L-Selectin | 1 | 2003 | 212 | 0.010 |
Why?
|
Gamma Rays | 1 | 2004 | 324 | 0.010 |
Why?
|
Acoustic Stimulation | 1 | 2007 | 1255 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6832 | 0.010 |
Why?
|
Reactive Oxygen Species | 1 | 2011 | 2140 | 0.010 |
Why?
|
Lung Diseases | 1 | 1993 | 1940 | 0.010 |
Why?
|
Phospholipase C gamma | 1 | 2003 | 130 | 0.010 |
Why?
|
Caffeine | 1 | 2007 | 702 | 0.010 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2006 | 618 | 0.010 |
Why?
|
Skin Tests | 1 | 2004 | 630 | 0.010 |
Why?
|
Receptors, CXCR4 | 1 | 2007 | 728 | 0.010 |
Why?
|
Type C Phospholipases | 1 | 2003 | 285 | 0.010 |
Why?
|
Affect | 1 | 2010 | 1500 | 0.010 |
Why?
|
Organ Size | 1 | 2007 | 2260 | 0.010 |
Why?
|
Tyrosine | 1 | 2006 | 1428 | 0.010 |
Why?
|
Cell Degranulation | 1 | 2003 | 280 | 0.010 |
Why?
|
Expressed Sequence Tags | 1 | 2002 | 251 | 0.010 |
Why?
|
Mammary Tumor Virus, Mouse | 1 | 1981 | 41 | 0.010 |
Why?
|
Wiskott-Aldrich Syndrome Protein | 1 | 2002 | 163 | 0.010 |
Why?
|
Listeria | 1 | 2001 | 24 | 0.010 |
Why?
|
Defective Viruses | 2 | 1997 | 88 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 1994 | 2511 | 0.010 |
Why?
|
Syndrome | 1 | 2008 | 3271 | 0.010 |
Why?
|
Wiskott-Aldrich Syndrome Protein, Neuronal | 1 | 2001 | 88 | 0.010 |
Why?
|
Glucose Transporter Type 2 | 1 | 2001 | 61 | 0.010 |
Why?
|
District of Columbia | 1 | 2001 | 159 | 0.010 |
Why?
|
Prognosis | 1 | 2002 | 29922 | 0.010 |
Why?
|
Lateral Ventricles | 1 | 2002 | 142 | 0.010 |
Why?
|
Epithelium | 2 | 1996 | 1599 | 0.010 |
Why?
|
Collagen Type XVIII | 1 | 2001 | 52 | 0.010 |
Why?
|
Hematopoietic Stem Cell Mobilization | 1 | 2002 | 227 | 0.010 |
Why?
|
Leukoplakia, Oral | 1 | 2001 | 79 | 0.010 |
Why?
|
Reaction Time | 1 | 2007 | 2086 | 0.010 |
Why?
|
E-Selectin | 1 | 2003 | 576 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 2 | 2004 | 8102 | 0.010 |
Why?
|
Chicago | 1 | 2001 | 255 | 0.010 |
Why?
|
Transcription Factors | 2 | 2011 | 12131 | 0.010 |
Why?
|
Leukoplakia, Hairy | 1 | 2000 | 10 | 0.010 |
Why?
|
Antigens, CD7 | 1 | 2000 | 30 | 0.010 |
Why?
|
Neoplastic Stem Cells | 1 | 1989 | 1352 | 0.010 |
Why?
|
Morphogenesis | 2 | 2001 | 744 | 0.010 |
Why?
|
Secretory Rate | 1 | 2000 | 82 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2004 | 813 | 0.010 |
Why?
|
Excipients | 1 | 2001 | 95 | 0.010 |
Why?
|
Chromosomes | 1 | 1984 | 578 | 0.010 |
Why?
|
Shigella flexneri | 1 | 2001 | 118 | 0.010 |
Why?
|
Amino Acid Motifs | 1 | 2003 | 924 | 0.010 |
Why?
|
Neoplasm Staging | 2 | 2006 | 11206 | 0.010 |
Why?
|
Lymphocyte Count | 1 | 2002 | 790 | 0.010 |
Why?
|
Submandibular Gland | 1 | 2000 | 83 | 0.010 |
Why?
|
Hyperplasia | 1 | 2003 | 1144 | 0.010 |
Why?
|
Cytotoxins | 1 | 2001 | 154 | 0.010 |
Why?
|
rac GTP-Binding Proteins | 1 | 2001 | 164 | 0.010 |
Why?
|
Cisplatin | 1 | 2006 | 1658 | 0.010 |
Why?
|
Retinal Vessels | 1 | 2006 | 863 | 0.010 |
Why?
|
cdc42 GTP-Binding Protein | 1 | 2001 | 187 | 0.010 |
Why?
|
Chloride Channels | 2 | 1991 | 221 | 0.010 |
Why?
|
Chromosome Deletion | 2 | 1983 | 1385 | 0.010 |
Why?
|
Dentists | 1 | 2001 | 176 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2004 | 1740 | 0.010 |
Why?
|
Vaccinia virus | 1 | 2001 | 327 | 0.010 |
Why?
|
Oral Ulcer | 1 | 2000 | 94 | 0.010 |
Why?
|
Angioplasty, Balloon | 1 | 2003 | 608 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 1999 | 5849 | 0.010 |
Why?
|
HIV Seronegativity | 1 | 2000 | 209 | 0.010 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2000 | 355 | 0.010 |
Why?
|
Sequence Analysis, RNA | 1 | 2007 | 2034 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 1995 | 4353 | 0.010 |
Why?
|
rho GTP-Binding Proteins | 1 | 2001 | 280 | 0.010 |
Why?
|
Nucleic Acid Precursors | 1 | 1979 | 16 | 0.010 |
Why?
|
Dimerization | 1 | 2001 | 880 | 0.010 |
Why?
|
Parotid Gland | 1 | 2000 | 177 | 0.010 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2000 | 303 | 0.010 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2002 | 568 | 0.010 |
Why?
|
Bioprosthesis | 1 | 2003 | 589 | 0.010 |
Why?
|
Up-Regulation | 1 | 2008 | 4137 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2001 | 615 | 0.010 |
Why?
|
New York City | 1 | 2001 | 733 | 0.010 |
Why?
|
Diffusion | 1 | 2001 | 808 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2008 | 3421 | 0.010 |
Why?
|
Anticoagulants | 1 | 1994 | 4862 | 0.010 |
Why?
|
Receptors, Fc | 1 | 2002 | 536 | 0.010 |
Why?
|
Salivary Glands | 1 | 2000 | 231 | 0.010 |
Why?
|
Lung | 2 | 1996 | 10033 | 0.010 |
Why?
|
Down-Regulation | 1 | 2006 | 2927 | 0.010 |
Why?
|
Odds Ratio | 2 | 2001 | 9649 | 0.010 |
Why?
|
RNA Interference | 1 | 2007 | 2832 | 0.010 |
Why?
|
bcl-X Protein | 1 | 2000 | 414 | 0.010 |
Why?
|
S100 Proteins | 1 | 1999 | 217 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2007 | 3160 | 0.010 |
Why?
|
Liver Transplantation | 1 | 1990 | 2412 | 0.010 |
Why?
|
Methods | 1 | 1979 | 1052 | 0.010 |
Why?
|
Cardiomyopathies | 1 | 2011 | 2067 | 0.010 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 1991 | 452 | 0.010 |
Why?
|
Fanconi Anemia Complementation Group Proteins | 1 | 1998 | 98 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2002 | 2745 | 0.010 |
Why?
|
Sequence Alignment | 1 | 2002 | 2171 | 0.010 |
Why?
|
Immune Sera | 1 | 1998 | 601 | 0.010 |
Why?
|
Japan | 1 | 2002 | 1415 | 0.010 |
Why?
|
Myocardium | 1 | 2011 | 4760 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2002 | 1831 | 0.010 |
Why?
|
Mitomycin | 1 | 1998 | 261 | 0.010 |
Why?
|
Dermatitis, Contact | 1 | 1998 | 135 | 0.010 |
Why?
|
California | 1 | 2001 | 1436 | 0.010 |
Why?
|
Receptors, Cytokine | 1 | 1998 | 258 | 0.010 |
Why?
|
Immunoglobulin Fc Fragments | 1 | 1999 | 287 | 0.010 |
Why?
|
Smoking | 1 | 2014 | 9081 | 0.010 |
Why?
|
DNA Helicases | 1 | 2002 | 852 | 0.010 |
Why?
|
Infection Control | 1 | 2004 | 983 | 0.010 |
Why?
|
Receptors, Thrombopoietin | 1 | 1998 | 157 | 0.010 |
Why?
|
Cornea | 1 | 2004 | 1316 | 0.010 |
Why?
|
Capillaries | 1 | 2000 | 755 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2000 | 2548 | 0.010 |
Why?
|
Particle Size | 1 | 2001 | 1631 | 0.010 |
Why?
|
Pulmonary Surfactant-Associated Proteins | 1 | 1996 | 18 | 0.010 |
Why?
|
DNA Repair | 1 | 2006 | 2048 | 0.010 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 1996 | 32 | 0.010 |
Why?
|
1,2-Dipalmitoylphosphatidylcholine | 1 | 1996 | 40 | 0.010 |
Why?
|
Peer Review, Research | 1 | 1999 | 341 | 0.010 |
Why?
|
Protein Isoforms | 1 | 2001 | 1718 | 0.010 |
Why?
|
Mice, Inbred MRL lpr | 1 | 1996 | 159 | 0.010 |
Why?
|
Gonadotropins, Equine | 1 | 1995 | 7 | 0.010 |
Why?
|
Logistic Models | 2 | 2001 | 13266 | 0.010 |
Why?
|
Receptors, Urokinase Plasminogen Activator | 1 | 1996 | 74 | 0.010 |
Why?
|
Lysophosphatidylcholines | 1 | 1996 | 77 | 0.010 |
Why?
|
RNA Probes | 1 | 1995 | 110 | 0.010 |
Why?
|
Palmitates | 1 | 1996 | 68 | 0.010 |
Why?
|
Codon, Initiator | 1 | 1996 | 50 | 0.010 |
Why?
|
DNA Damage | 1 | 2006 | 2457 | 0.010 |
Why?
|
Fibrinolysin | 1 | 1996 | 129 | 0.010 |
Why?
|
Culture Techniques | 1 | 1996 | 515 | 0.010 |
Why?
|
Protein Binding | 1 | 2008 | 9296 | 0.010 |
Why?
|
Peptide Biosynthesis | 1 | 1975 | 52 | 0.010 |
Why?
|
Caseins | 1 | 1995 | 105 | 0.010 |
Why?
|
Saliva | 1 | 2000 | 851 | 0.010 |
Why?
|
Bacterial Toxins | 1 | 2001 | 924 | 0.010 |
Why?
|
Antifungal Agents | 1 | 2000 | 769 | 0.010 |
Why?
|
Macrophages, Peritoneal | 1 | 1996 | 243 | 0.010 |
Why?
|
HIV Seropositivity | 1 | 2000 | 961 | 0.010 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2004 | 1892 | 0.010 |
Why?
|
DNA Probes | 1 | 1995 | 541 | 0.010 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 1 | 1996 | 305 | 0.010 |
Why?
|
Th2 Cells | 1 | 2000 | 1075 | 0.010 |
Why?
|
Avoidance Learning | 1 | 1996 | 248 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2000 | 2844 | 0.010 |
Why?
|
Phosphatidylcholines | 1 | 1996 | 403 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2012 | 39193 | 0.010 |
Why?
|
Neomycin | 2 | 1984 | 94 | 0.010 |
Why?
|
Congresses as Topic | 1 | 1999 | 811 | 0.010 |
Why?
|
Chondroitin Sulfates | 1 | 1994 | 173 | 0.010 |
Why?
|
Carbohydrate Sequence | 1 | 1994 | 410 | 0.010 |
Why?
|
Choline | 1 | 1996 | 510 | 0.010 |
Why?
|
United States | 1 | 2002 | 72903 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2002 | 3797 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2000 | 3432 | 0.010 |
Why?
|
Virus Integration | 1 | 1996 | 304 | 0.010 |
Why?
|
Chromatin | 1 | 2006 | 2980 | 0.010 |
Why?
|
Drug Eruptions | 1 | 1997 | 335 | 0.010 |
Why?
|
Cell Count | 1 | 1998 | 1823 | 0.010 |
Why?
|
Eosinophils | 1 | 1998 | 945 | 0.010 |
Why?
|
Recurrence | 1 | 2006 | 8501 | 0.010 |
Why?
|
Prospective Studies | 2 | 2013 | 54802 | 0.010 |
Why?
|
Erythrocyte Count | 1 | 1993 | 158 | 0.010 |
Why?
|
Space Perception | 1 | 1996 | 469 | 0.010 |
Why?
|
Cecum | 1 | 1993 | 232 | 0.010 |
Why?
|
Feedback | 1 | 1996 | 796 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 1996 | 1478 | 0.010 |
Why?
|
Parathyroid Glands | 1 | 1974 | 521 | 0.010 |
Why?
|
Superoxides | 1 | 1993 | 383 | 0.010 |
Why?
|
Glucocorticoids | 1 | 1981 | 2132 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8041 | 0.010 |
Why?
|
Stromal Cells | 1 | 1997 | 1329 | 0.010 |
Why?
|
Immunoglobulin Variable Region | 1 | 1993 | 419 | 0.010 |
Why?
|
Transplantation, Isogeneic | 1 | 1992 | 251 | 0.010 |
Why?
|
Immunity | 1 | 1998 | 1002 | 0.010 |
Why?
|
Survival Rate | 1 | 2006 | 12795 | 0.010 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2000 | 2203 | 0.010 |
Why?
|
Hedgehog Proteins | 1 | 1996 | 774 | 0.010 |
Why?
|
Neutrophils | 1 | 2004 | 3776 | 0.010 |
Why?
|
Radiography | 1 | 2002 | 6919 | 0.010 |
Why?
|
Endotoxins | 1 | 1993 | 516 | 0.010 |
Why?
|
Skin Physiological Phenomena | 1 | 1992 | 193 | 0.010 |
Why?
|
Viral Load | 1 | 2000 | 3386 | 0.010 |
Why?
|
Rats, Inbred F344 | 1 | 1992 | 822 | 0.010 |
Why?
|
Platelet Count | 1 | 1993 | 782 | 0.010 |
Why?
|
Regression Analysis | 1 | 2000 | 6322 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1992 | 2077 | 0.010 |
Why?
|
Osteoblasts | 1 | 1996 | 1143 | 0.010 |
Why?
|
Age Factors | 1 | 2007 | 18380 | 0.010 |
Why?
|
Electric Conductivity | 1 | 1991 | 403 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1990 | 417 | 0.010 |
Why?
|
Clinical Protocols | 1 | 1996 | 1441 | 0.010 |
Why?
|
Cell Cycle | 1 | 1998 | 2920 | 0.010 |
Why?
|
Open Reading Frames | 1 | 1993 | 820 | 0.010 |
Why?
|
Parathyroidectomy | 1 | 1992 | 244 | 0.010 |
Why?
|
Trachea | 1 | 1996 | 1085 | 0.010 |
Why?
|
Gonadotropin-Releasing Hormone | 1 | 1995 | 1133 | 0.010 |
Why?
|
Calcium | 1 | 2003 | 5767 | 0.010 |
Why?
|
RNA, Antisense | 1 | 1989 | 135 | 0.010 |
Why?
|
Embryonal Carcinoma Stem Cells | 1 | 1989 | 20 | 0.010 |
Why?
|
Bucladesine | 1 | 1989 | 117 | 0.000 |
Why?
|
Behavior, Animal | 1 | 1996 | 1865 | 0.000 |
Why?
|
Membrane Potentials | 1 | 1991 | 1083 | 0.000 |
Why?
|
Remission Induction | 1 | 1994 | 2411 | 0.000 |
Why?
|
Epitopes | 1 | 1994 | 2523 | 0.000 |
Why?
|
Neuronal Plasticity | 1 | 1996 | 1445 | 0.000 |
Why?
|
Herpesvirus 4, Human | 1 | 1993 | 1078 | 0.000 |
Why?
|
Keratins | 1 | 1989 | 498 | 0.000 |
Why?
|
Hemoglobins | 1 | 1993 | 1530 | 0.000 |
Why?
|
Internet | 1 | 1999 | 3106 | 0.000 |
Why?
|
HLA-DP Antigens | 1 | 1987 | 25 | 0.000 |
Why?
|
Biopsy | 1 | 1999 | 6763 | 0.000 |
Why?
|
Cyclic AMP | 1 | 1991 | 1467 | 0.000 |
Why?
|
Colchicine | 1 | 1988 | 256 | 0.000 |
Why?
|
Vinblastine | 1 | 1988 | 483 | 0.000 |
Why?
|
Thyroidectomy | 1 | 1992 | 916 | 0.000 |
Why?
|
Disease Progression | 1 | 2003 | 13632 | 0.000 |
Why?
|
Sarcoma, Experimental | 1 | 1986 | 116 | 0.000 |
Why?
|
Embolization, Therapeutic | 1 | 1996 | 1403 | 0.000 |
Why?
|
Immunoblotting | 1 | 1989 | 1644 | 0.000 |
Why?
|
Tretinoin | 1 | 1989 | 524 | 0.000 |
Why?
|
Neural Pathways | 1 | 1996 | 3085 | 0.000 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1986 | 255 | 0.000 |
Why?
|
Moloney murine sarcoma virus | 1 | 1984 | 4 | 0.000 |
Why?
|
Isoenzymes | 1 | 1989 | 1689 | 0.000 |
Why?
|
Genes, Synthetic | 1 | 1985 | 88 | 0.000 |
Why?
|
Feasibility Studies | 1 | 1996 | 5302 | 0.000 |
Why?
|
Chimera | 1 | 1986 | 455 | 0.000 |
Why?
|
Risk Assessment | 1 | 2006 | 24282 | 0.000 |
Why?
|
Anti-HIV Agents | 1 | 2000 | 4559 | 0.000 |
Why?
|
Cell-Free System | 2 | 1975 | 339 | 0.000 |
Why?
|
Crosses, Genetic | 1 | 1985 | 752 | 0.000 |
Why?
|
Virus Activation | 1 | 1986 | 323 | 0.000 |
Why?
|
Cross Reactions | 1 | 1986 | 824 | 0.000 |
Why?
|
Skin | 1 | 1998 | 4489 | 0.000 |
Why?
|
HIV-1 | 1 | 2001 | 6944 | 0.000 |
Why?
|
Metaphase | 1 | 1984 | 144 | 0.000 |
Why?
|
Azacitidine | 1 | 1985 | 334 | 0.000 |
Why?
|
Databases, Factual | 1 | 1999 | 8067 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1997 | 12437 | 0.000 |
Why?
|
DNA Mutational Analysis | 1 | 1991 | 4108 | 0.000 |
Why?
|
Ultrasonography | 1 | 1996 | 5993 | 0.000 |
Why?
|
Cholesterol | 1 | 1990 | 2898 | 0.000 |
Why?
|
Receptors, Immunologic | 1 | 1987 | 1415 | 0.000 |
Why?
|
Pulmonary Embolism | 1 | 1993 | 2598 | 0.000 |
Why?
|
Genetic Linkage | 1 | 1984 | 2341 | 0.000 |
Why?
|
CHO Cells | 1 | 1981 | 1372 | 0.000 |
Why?
|
Repressor Proteins | 1 | 1989 | 2968 | 0.000 |
Why?
|
Pituitary Neoplasms | 1 | 1984 | 1321 | 0.000 |
Why?
|
Gestational Age | 1 | 1984 | 3609 | 0.000 |
Why?
|
Algorithms | 1 | 1996 | 14071 | 0.000 |
Why?
|
Goats | 1 | 1975 | 166 | 0.000 |
Why?
|
Triticum | 1 | 1975 | 92 | 0.000 |
Why?
|
Chromatography, Paper | 1 | 1974 | 76 | 0.000 |
Why?
|
Cyanogen Bromide | 1 | 1974 | 75 | 0.000 |
Why?
|
Bacillus | 1 | 1975 | 76 | 0.000 |
Why?
|
Haemophilus influenzae | 1 | 1975 | 176 | 0.000 |
Why?
|
Chemical Precipitation | 1 | 1974 | 173 | 0.000 |
Why?
|
Precipitin Tests | 1 | 1975 | 812 | 0.000 |
Why?
|
Tritium | 1 | 1974 | 702 | 0.000 |
Why?
|
Plants | 1 | 1975 | 331 | 0.000 |
Why?
|
Leucine | 1 | 1974 | 546 | 0.000 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 1975 | 368 | 0.000 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1974 | 1724 | 0.000 |
Why?
|
Methionine | 1 | 1974 | 569 | 0.000 |
Why?
|
Potassium | 1 | 1975 | 1311 | 0.000 |
Why?
|
Lysine | 1 | 1974 | 991 | 0.000 |
Why?
|
Cattle | 1 | 1974 | 3801 | 0.000 |
Why?
|